Migraine (chronic) - botulinum toxin type A: Evidence Review Group critique of Allergan response to request for additional evidence
|
Migraine (chronic) - botulinum toxin type A: Evidence Review Group critique of Allergan response to request for additional evidence
11 May 2012 (124.95 Kb 36 sec) |
This page was last updated: 08 May 2012